Inventor · disambiguated record
Andiliy G. Lai
Also filed as: LAI ANDILIY · LAI ANDILIY G · LAI ANDILIY GOKCHING
19 granted patents·17 pending applications·248 citations·filing 2004–2024
95Inventor score
Files withAMBIT BIOSCIENCES CORP13METACRINE INC6PHARMAKEA INC3SERAGON PHARMACEUTICALS INC3SMITH NICHOLAS D3
Top patents by PatentIndex Score
36 records- 0197US8455534B2Estrogen receptor modulators and uses thereofSMITH NICHOLAS D·Filed 2012·Granted Jun 4, 2013·66 cites·18 claims
- 0297US8299112B2Estrogen receptor modulators and uses thereofSMITH NICHOLAS D·Filed 2011·Granted Oct 30, 2012·72 cites·12 claims
- 0391US9193714B2Fluorinated estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2012·Granted Nov 24, 2015·18 cites·14 claims
- 0490US8618289B2RAF kinase modulator compounds and methods of use thereofABRAHAM SUNNY·Filed 2009·Granted Dec 31, 2013·22 cites·26 claims
- 0589US9320739B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2015·Granted Apr 26, 2016·6 cites·11 claims
- 0688US9187460B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2012·Granted Nov 17, 2015·11 cites·17 claims
- 0788US8969587B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2013·Granted Mar 3, 2015·8 cites·14 claims
- 0887US11773094B2Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2021·Granted Oct 3, 2023·1 cites·19 claims
- 0985US2025289821A1Farnesoid x receptor agonists and uses thereofLILLY CO ELI·Filed 2024·Application pending·0 cites
- 1084US11084817B2Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2019·Granted Aug 10, 2021·3 cites·15 claims
- 1183US9399646B2Estrogen receptor modulators and uses thereofSMITH NICHOLAS D·Filed 2011·Granted Jul 26, 2016·6 cites·15 claims
- 1283US7750160B2Isoxazolyl urea derivatives as kinase modulatorsAMBIT BIOSCIENCES CORP·Filed 2004·Granted Jul 6, 2010·17 cites·31 claims
- 1382US11236071B1Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2018·Granted Feb 1, 2022·2 cites·18 claims
- 1481US9926318B2Tetracyclic autotaxin inhibitorsPHARMAKEA INC·Filed 2014·Granted Mar 27, 2018·4 cites·17 claims
- 1580US2023382913A1Farnesoid x receptor agonists and uses thereofORGANOVO INC·Filed 2023·Application pending·0 cites
- 1678US10053430B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2017·Granted Aug 21, 2018·1 cites·2 claims
- 1778US9499538B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2013·Granted Nov 22, 2016·4 cites·13 claims
- 1877US10053451B2Heterocyclic estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted Aug 21, 2018·2 cites·10 claims
- 1975US9730937B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2016·Granted Aug 15, 2017·1 cites·19 claims
- 2070US7767670B2Substituted 3-carboxamido isoxazoles as kinase modulatorsAMBIT BIOSCIENCES CORP·Filed 2004·Granted Aug 3, 2010·4 cites·24 claims
- 2166US2022089575A1Farnesoid x receptor agonists and uses thereofMETACRINE INC·Filed 2021·Application pending·0 cites
- 2261US2005153989A1Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseasesAMBIT BIOSCIENCES CORP·Filed 2005·Application pending·0 cites
- 2361US2005165029A1Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseasesAMBIT BIOSCIENCES CORP·Filed 2005·Application pending·0 cites
- 2461US2024368127A1Hsd17b13 inhibitors and uses thereofFL2022 001 INC·Filed 2022·Application pending·0 cites
- 2560US9868704B2Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted Jan 16, 2018·0 cites·18 claims
- 2657US2024083853A1Hsd17b13 inhibitors and uses thereofFL2022 001 INC·Filed 2021·Application pending·0 cites
- 2757US2010048890A1Conjugated small moleculesGROTZFELD ROBERT M·Filed 2009·Application pending·0 cites
- 2853US2005187389A1Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseasesAMBIT BIOSCIENCES CORP·Filed 2005·Application pending·0 cites
- 2953US2004248957A1Heterocyclic compounds and uses thereofAMBIT BIOSCIENCES CORP·Filed 2004·Application pending·0 cites
- 3053US2004242673A1Heterocyclic compounds and uses thereofAMBIT BIOSCIENCES CORP·Filed 2004·Application pending·0 cites
- 3150US2018162859A1Tetracyclic autotaxin inhibitorsPHARMAKEA INC·Filed 2018·Application pending·0 cites
- 3247US2005153371A1Conjugated small moleculesAMBIT BIOSCIENCES CORP·Filed 2005·Application pending·0 cites
- 3346US2022056019A1Farnesoid x receptor agonists and uses thereofMETACRINE INC·Filed 2019·Application pending·0 cites
- 3445US2010173917A1Urea derivatives as abl modulatorsAMBIT BIOSCIENCES CORP·Filed 2010·Application pending·0 cites
- 3541US2020131129A1Farnesoid x receptor agonists and uses thereofMETACRINE INC·Filed 2018·Application pending·0 cites
- 3636US2017088520A1Deubiquitinase inhibitorsPHARMAKEA INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andiliy G. Lai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →